Effects of pemirolast and tranilast on intimal thickening after arterial injury in the rat

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 2, 1997, Pages 157-162

  Miyazawa, Norio ^a   Umemura, Kazuo ^a   Kondo, Kazunao ^a   Nakashima, Mitsuyoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endothelial injury; Intimal thickening; Migration; Pemirolast; Proliferation; Tranilast

Indexed keywords

BROXURIDINE; PEMIROLAST; PLATELET DERIVED GROWTH FACTOR; ROSE BENGAL; TRANILAST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; FEMORAL ARTERY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTHRANILIC ACIDS; ANTIMETABOLITES; ARTERIES; BROMODEOXYURIDINE; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HISTAMINE ANTAGONISTS; HISTAMINE H1 ANTAGONISTS; PYRIDINES; PYRIMIDINONES; RATS; TUNICA INTIMA;

EID: 0030784447     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199708000-00002     Document Type: Article

References (34)

1. Kaltenbach M, Kober G, Schere D, Vallbracht C. Recurrence rate after successful coronary angioplasty. Eur Heart J 1985;6:276-81.
2. Serruys PW, Luijten HE, Beatt KJ, et al. Incidence of restenosis after successful coronary angioplasty: a time related phenomenon: a quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988;77:361-71.
3. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med 1986;314:488-500.
4. Liu MW, Roubin GS, King SB III. Restenosis after coronary angioplasty: potential biologic determinant and role of intimai hyperplasia. Circulation 1989;79:1374-87.
5. Herbert JM, Tissinier A, Defreyn G, Maffrand JP. Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits. Arterioscler Thromb 1993;13:1171-9.
6. Faxon DP, Sanborn TA, Haudenschild CC, Ryan TJ. Effect of antiplatelet therapy on restenosis after experimental angioplasty. Am J Cardiol 1984;53:72C-6C.
7. Clowes AW, Clowes MM. Kinetics of cellular proliferation after arterial injury: heparin inhibits rat smooth muscle mitogenesis and migration. Circ Res 1986;58:839-45.
8. Edelman ER, Adams DH, Karnovsky MJ. Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc Natl Acad Sci USA 1990;87: 3773-7.
9. Currier JW, Pow TK, Haudenschild CC, Minihan AC, Faxon DP. Low molecular weight heparin (enoxapirin) reduces restenosis after iliac angioplasty in the hypercholesterolemic rabbit. J Am Coll Cardiol 1991;17:118B-25B.
10. Jackson CL, Bush RC, Bowyer DE. Inhibitory effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size. Atherosclerosis 1988;69:115-22.
11. Hiroyuki A, Mutoh S, Hirosumi J, Yamaguchi I. Effect of nilvadipine on balloon catheterization-induced intimai thickening of the coronary artery in miniature pigs. J Cardiovasc Pharmacol 1992;20:731-4.
12. Powell JS, Clozel JP, Müller RKM, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-8.
13. Schwartz L, Bourassa MG, Lespérance J, et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988;318:1714-9.
14. Whitworth HB, Roubin GS, Hollman J, et al. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1986;8:1271-6.
15. The Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) study group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty?: results of the MERCATOR study, a multicenter, randomized, double-blind placebo-controlled trial. Circulation 1992;86:100-10.
16. Kikuchi S, Umemura K, Kondo K, Nakashima M. Tranilast suppresses intimai hyperplasia after photochemically induced endothelial injury in the rat. Eur J Pharmacol 1996;295:221-7.
17. The TREAT study investigators. The impact of tranilast on restenosis following coronary angioplasty: the Tranilast Restenosis Following Angioplasty Trial (TREAT). Circulation 1994;90:I-652.
18. Kato K, Tamai H, Hayakawa H, et al. Clinical evaluation of tranilast on restenosis after percutaneous transluminal coronary angioplasty (PTCA) - a double-blind placebo-controlled comparative study. J Clin Ther Med 1996;12:65-85.
19. Tanaka K, Honda M, Kuramochi T, Morioka S. Prominent inhibitory effects of tranilast on migration and proliferation of and collagen synthesis by vascular smooth muscle cells. Atherosclerosis 1994;107:179-85.
20. Yanagihara Y, Kasai H, Kawashima T, Shida T. Immunopharmacological studies on TBX, a new antiallergic drug: (1) Inhibitory effects on passive cutaneous anaphylaxis in rats and guinea pigs. Jpn J Pharmacol 1988;48:91-101.
21. Yanagihara Y, Kasai H, Shida T. Immunopharmacological studies on TBX, a new antiallergic drug: (2) Inhibitory effects on histamine release from peritoneal mast cells and lung fragments of rats. Jpn J Pharmacol 1988;48:103-12.
22. Hirata Y, Umemura K, Kondoh K, Uematsu T, Nakashima M. Experimental intimai thickening studies using the photochemically induced thrombosis model in the guinea-pig femoral artery. Atherosclerosis 1994;107:117-24.
23. Umemura K, Toshima Y, Asai F, Nakashima M. Effect of dietary docosahexaenoic acid enhances thrombolytic effect of tissue-type plasminogen activator in the rat middle cerebral artery thrombosis model. Thromb Res 1995;78:379-87.
24. 2 in a microcirculation disorder of the rat inner ear. Eur Arch Otorhinolaryngol 1993;250:342-4.
25. Hirata Y, Umemura K, Uematsu T, Nakashima M. An experimental myocardial infarction model in the rat and its properties. Jpn J Pharmacol 1995;67:51-7.
26. Saniabadi AR. Photosensitisers and photochemical reactions. In: Nakashima M, ed. A novel photochemical model for thrombosis research and evaluation of antithrombotic and thrombolytic agents. London: Churchill Livingstone, 1994:1-19.
27. Fujimiya H, Nakashima S, Miyata H, Nozawa Y. Effect of a novel antiallergic drug, pemirolast, on activation of rat peritoneal mast cells: inhibition of exocytotic response and membrane phospholipid turnover. Int Arch Allergy Appl Immunol 1991;96:62-7.
28. 2+ mobilization in antigen-stimulated rat basophilic leukemia (RBL-2H3) cells. Jpn J Allergol 1994;43:142-51.
29. Ninomiya K, Matsuoka S, Matsui S, Hiratsuka S, Ohmura S, Hosono J. General pharmacological study of TBX. Jpn J Pharmacol Ther 1989;17:1249-79.
30. Valius M, Kazlauskas A. Phospholipase C-τ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 1993;73:321-34.
31. Newby AC, Lim K, Evans MA, Brindle NPJ, Booth RFG. Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C. Br J Pharmacol 1995;114:1652-6.
32. Ohsawa H, Kanai M, Noike H, et al. Effects of pemirolast potassium on prevention of angiographic restenosis after percutaneous transluminal coronary angioplasty. Jpn Circ J 1995;59:390-1.
33. 2 from human monocytes-macrophages. Jpn J Pharmacol 1992;60:85-90.
34. Kawashima T, Iwamoto I, Nakagawa N, Tomioka H, Yoshida S. Inhibitory effect of pemirolast, a novel antiallergic drug, on leukotriene C4 and granule protein release from human eosinophils. Int Arch Allergy Appl Immunol 1994;103:405-9.